News
Hims & Hers (NYSE: HIMS) stock has been on fire in 2025, and the company just got more great news after upsizing a $450 million convertible debt offering to up to $1 billion. The growth of Hims & Hers ...
Health and wellness companies are embracing weight-loss drugs and building offerings around them in an effort to avoid the ...
For an hour, Beth and I sang showtunes for our mother — in their entirety when we could, and snippets when we couldn’t. When ...
The WXII 12 sports team is launching a brand-new, exclusive segment shining a spotlight on trailblazing women in sports ...
Former Meta and Time Warner exec Mark D'Arcy is joining Microsoft as a corporate vice president working on the tech ...
Former Taconic softball player Taylar Ostrander passed away unexpectedly on April 17 at 23 years old. “Once a Brave, always a ...
Police are hunting for a man caught on video slashing a transgender woman’s tires at a Los Angeles gas station and telling ...
Friends may have ended in 2004, but the debates? Like Joey’s love for sandwiches—eternal. It’s been thirty years since we met the Central Perk crew, and ...
Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...
Nader Kabbani, who spent almost 20 years at the e-commerce giant, joins the health startup as chief operations officer.
As Stat reports, the federal judge's ruling means patients will lose access to less-expensive versions of Eli Lilly's weight loss drug, as well as diabetes treatment Mounjaro, from compounding ...
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results